XML 61 R47.htm IDEA: XBRL DOCUMENT
v3.24.1

Summary of Significant Account Policies (Details) - Schedule of Diluted Net Loss Per Share - shares | 12 Months Ended
--- | ---
Dec. 31, 2023 | Dec. 31, 2022
Schedule of Diluted Net Loss Per Share [Abstract] |  |
Total potentially dilutive securities | 109,185,573 | 29,603,540
Warrants to purchase common stock [Member] |  |
Schedule of Diluted Net Loss Per Share [Abstract] |  |
Total potentially dilutive securities | 12,566,092 | 1,901,802
Options to purchase common stock [Member] |  |
Schedule of Diluted Net Loss Per Share [Abstract] |  |
Total potentially dilutive securities | 4,854,507 | 2,412,286
Potential shares issuable under 2022 Convertible Exchange Notes [Member] |  |
Schedule of Diluted Net Loss Per Share [Abstract] |  |
Total potentially dilutive securities | 62,084,776 | 24,177,835
Potential shares issuable under 2023 Additional Notes [Member] |  |
Schedule of Diluted Net Loss Per Share [Abstract] |  |
Total potentially dilutive securities | 29,125,732 |
Restricted stock units [Member] |  |
Schedule of Diluted Net Loss Per Share [Abstract] |  |
Total potentially dilutive securities | 554,466 | 1,111,617

X
- References No definition available. + Details
Name: | onds_SummaryofSignificantAccountPoliciesDetailsScheduleofDilutedNetLossPerShareLineItems
Namespace Prefix: | onds_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_OptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=onds_PotentialSharesIssuableUnder2022ConvertibleExchangeNotesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=onds_PotentialSharesIssuableUnder2023AdditionalNotesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |